{"nct_id":"NCT06191796","title":"Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)","status":"TERMINATED","status_verified_date":"2025-06","start_date":"2024-01-25","start_date_type":"ACTUAL","primary_completion_date":"2025-05-12","primary_completion_date_type":"ACTUAL","completion_date":"2025-05-12","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["EXEL"]}